All news

Odyssey Therapeutics holds $35.33 consensus price target

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

Odyssey Therapeutics (NASDAQ:ODTX) carries a consensus "Moderate Buy" rating from ten research firms, with an average 12-month price target of $35.33 versus a current share price of

Read original source

ODTX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.